GUIDANCE Rev. 1
Guideline on Strategies to Identify and Mitigate Risks for First-in-Human and Early Clinical Trials
ABSTRACT — EDITORS' SUMMARY
FIH-specific risk identification and mitigation. Critical for sponsor protocol design and oversight of phase 1 unit trials.
EMBEDDED PDF
METADATA
SOURCE
PDF · CANONICAL LINK https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-strategies-identify-and-mitigate-risks-first-human-and-early-clinical-trials-investigational-medicinal-products-revision-1_en.pdf ↗ RELATED · SAME AUTHORITY